Conexeu Sciences (CNXU) stock

Collagen devices , market cap $102M

Collagen devices for wounds and dentistry

Market cap $102M

$2.94

-5.16%

As of Monday's close · Live for Pro members at the open

Quality Score

-3

Poor

In its industry

#77of 85

Medical Devices

Checks firing

1of 14

Choppy

From its high

-84.4%

No 200-day yet

CNXU's Quality Score fell 2 points on Mon, Oct 26, to -3. Its volume picked back up (2 chart checks stopped).

New listing, trading since May 21, 2026. 109 trading days so far, so 3 of the 14 chart checks wait for more history.

See CNXU's 14 chart checksSee it live, free until Wednesday morning. No account. No card. Then keep going with a free account.

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

Why is CNXU down?

Down 60% in 3 months, 39% under its 50-day average.

Its industry held up: the 83 other stocks in it rose a median 4% over the same 3 months.

−2Dilution 91.3% more shares outstanding than a year ago

2 more things pulling CNXU's score down, for Pro members.

Key facts on CNXU

Key facts on CNXU
Holding it back	91.3% more shares than a year ago
Latest filing	8-K, Oct 20 Sold shares in an unregistered sale

3 more reasons behind CNXU's -3, for Pro members.

CNXU in the news

TodayNo story names it yet.

What's next

Fri May 21: One year since its IPOListed May 21, 2026 at $4.

Get an alert when CNXU's Quality Score turns up →

Tested. Our top-⁠scored stocks returned 2.2x the average stock over the next month. How we tested it

CNXU catalysts

Coming up

Here is what Pro members see.

The same page for Pro members, on AMD
Its Quality Score and rank, the line that drives it, and the live price.
The full chart
A year of candles to start, out to the whole history, with insider trades marked and the Quality Score under the price.
Every line of the score
Price action, the company, and signals, each with its points, on CNXU and every other stock.
CEOs buying their own stock
Every CEO buy, biggest names first. Sort, filter, save the list, and set optional alerts.
Congress trades
A member's trades, newest first, each with its amount. Sort and filter the whole list.
14 chart checks, read for you
The ones firing on the stock, each in plain words, its rule a tap away.
Earnings, week by week
Who reports each day, and how each stock took its last four reports.
FDA dates, counted down
Each date in the company's words, its cash against the date, and an optional alert before it.
The market map
Every stock a box, colored by its Quality Score.
Themes, ranked live
Each theme's stocks ranked by Quality Score, live. Here, AI chips.
The top 10, every day
The ten highest Quality Scores at each close, kept day by day, week by week.
Optional alerts, your way
Pick a stock, a score, a price, a filing, or a whole scan. It tells you by push or email.
Your watchlist, scored
Your stocks by Quality Score, today's move, or name.
On your phone and your laptop
The same account and watchlist on both, each laid out for its screen.

Prices refresh every 2.5 seconds during market hours.
Optional alerts by push, email, or the bell.
Add it to your Home Screen and it opens like an app.

CNXU has 1 of 14 chart checks firing

Trend1 of 5 shown

MA FAN 21 EMA W.EMA HH/HL 52W HI

Volume1 of 3 shown

VOL VDU U/D VOL

Tight range1 of 3 shown

ATR SQZ SQUEEZE NR7

Buying1 of 3 shown

OBV+CLOSE HI SPRING

The other 10 checks on CNXU, and all 14 on every stock.Get in free →

CNXU RSI today: 38.2, below its 50-day average

Not scored

Not in the Quality Score: over 20 years of tests, 2006 to 2026, they added no edge.

RSI 1438.2
Above 30, below 50.
MACD (12, 26, 9)Above signal
Crossed above its signal line 27 sessions ago.
50-day average$4.95
The price is 40.6% below it.
200-day average
Not enough history yet.
50/200 cross
Not enough history yet.
ADX 1416.6
Under 25, with +DI below -DI.
Support
No swing low under the price in the last year.
Resistance$4.36
Swing high from Oct 14, 48.3% above the price.
High since listing$18.79
From Jun 3, 539.2% above the price.
Low since listing$2.90
From Oct 26, 1.4% below the price.
Chart patternWedge
Lines over the Aug 17 and Oct 14 highs and under the Oct 5 and Oct 20 lows.
Bollinger Bands (20, 2)Inside
The bands run from $2.81 to $4.00.
Volume0.8x
Against its 20-day average, for the time of day.

The deep dive on CNXU

What it does and how it makes money1 findingFor Pro members1 finding on what CNXU does and how it makes money, for Pro members
Where it stands2 findingsIts share count rose 91.3% in the year to Jul 31, 2026.Weighted shares, the quarter to Jul 31, 2026
Who holds and trades it3 findingsFor Pro members3 findings on who holds and trades CNXU, for Pro members

5 more findings on CNXU, each with its source, for Pro membersGet in free →

How CNXU ranks in Medical Devices

CNXU is #77 of 85 by Quality Score.

How CNXU ranks in Medical Devices
1	HAEHaemonetics	10/14	20
2	ATRCAtriCure	8/14	19
3	WSTWest Pharmaceutical Services	7/14	17
	CLPTClearPoint Neuro		Open for its score
	CNMDCONMED		Open for its score
	COOThe Cooper Companies		Open for its score
	DCTHDelcath Systems		Open for its score
77	CNXUConexeu Sciences	1/14	-3

When does CNXU report earnings, and what happens after?

Expected to report Fri Jan 22, after the close (in 88 days). Expected.

What an earnings report is: every 3 months, a company tells everyone how much it sold and earned. We read the figures, the outlook, and how the stock moved after.

CNXU share count over time

Shares: 91.3% more than a year ago (to Jul 31).

Shares of CNXU outstanding, as filed
Shares outstanding	As of
28.2M	Sep 10, 2026
26.8M	Jun 10, 2026

Offerings, shelves, and splits of CNXU, from its filings
From its filings	Filed
Unregistered sale of CNXU shares	Oct 20, 2026

Who is trading CNXU

CNXU insider trades

One insider bought $662K across 2 filings in the last 6 months. No open-⁠market sales on record. The newest:

BuyLynn Sebastian Purcell$500K10% ownerat $3.00 on Oct 15, filed Oct 19

BuyLynn Sebastian Purcell10% owner$500Kat $3.00 on Oct 15, filed Oct 19

All 2 insider filings on CNXU from the last six months, for Pro members.Get in free →

CNXU's officers and directors

Officers and directors with a Form 4 in the last 12 months.

David Robert BogartChief Commercial Officer
Jeffrey Nathan SharpeDirector

See insider trades by person

About Conexeu Sciences

Conexeu Sciences Inc is an early-stage medical technology company. The company develops and supplies collagen-based technologies that helps doctors and patients regenerate tissue naturally, safely, and effectively. The company is focused on developing regenerative biomaterials that address relative needs in wound care, dentistry, and aesthetics. The company seek to provide physicians with device-based solutions that improve healing, restore soft tissue, and enhance patient outcomes across multiple clinical settings. The company focuses durable, and growing addressable markets in regenerative aesthetics, wound care, 3D-printed tissue structures, veterinary wound repair, and dental soft-tissue regeneration.

Reno, NVconexeu.com

Listed on Nasdaq on May 21, 2026, and is 27% below its $4 offer price now. The offer price is from Massive's IPO calendar.

CNXU's score card

Conexeu Sciences (CNXU): Quality Score -3, Poor, #77 of 85 in Medical Devices, with its price, on Breakaway — The picture a link to this page shows when it is shared.

Pro members see every line of every stock's score.

What would turn CNXU's score around: 4 things
1 more filing explained, a plain line each
Real-⁠time prices, no delay

BreakawayOct 19Lynn Sebastian Purcell bought CNXU$500K at $3.00, filed Oct 19

Alerts are optional.

See CNXU's 14 chart checks

See it live, free until Wednesday morning. No account. No card. Then keep going with a free account.

Straight Answers

As of Oct 26, 2026: CNXU's Quality Score is -3 (Poor), #77 of 85 in Medical Devices. Insiders bought $662K in the last 6 months (Form 4).

Is CNXU a good stock to buy? What its Quality Score says

CNXU scores -3 today, which Breakaway calls Poor. It is #77 of 85 in Medical Devices by Quality Score, with 1 of 14 chart checks firing. Down 60% in 3 months, 39% under its 50-⁠day average. Shares: 91.3% more than a year ago (to Jul 31). Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.

What is CNXU's Quality Score?

CNXU scores -3 today, which Breakaway calls Poor (below zero). That is #77 of 85 in Medical Devices by Quality Score. The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind CNXU's -3.

Are insiders buying CNXU?

One insider bought $662K across 2 filings in the last 6 months. No open-⁠market sales on record. The newest is Lynn Sebastian Purcell, 10% owner, who bought $500K on Oct 15. Every filing, with the scored weight, for Pro members.

Are the prices delayed?

Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.